Clinical comparison of two radiocolloids for internal mammary lymphoscintigraphy.
Recent studies suggest that 99mTc-labeled radiocolloid (SC) compounded with hydrogen sulfide can be used to visualize lymph channels and nodes. Our study prospectively compared SC with 99mTc antimony sulfide (SbS) colloid, in 28 patients undergoing internal mammary lymphoscintigraphy. Images were recorded on a scintillation camera and computer at 0.5, 1.0, and 3.0 hr. Quantitative analysis included assessment of percent (%) injected dose in nodes, the percent remaining at the injection site, and the relative intensity of the most cephalad node compared to a 57Co standard. The mean (means) % injected dose of both radiocolloids within visualized nodes was less than 1% at each time interval, with no significant differences between means's. The means % injected dose remaining at the injection site at 3.0 hr was 83 for SbS and 76 for SC not statistically significant (N.S.). The means of the ratio of counts within the most cephalad node at 3.0 hr to counts within a 57Co standard was 0.98 for SbS and 1.03 for SC (N.S.). Clinical assessment of number of nodes visualized and extent of radiocolloid migration showed no difference between the two agents. The biological and clinical parameters for the two colloids appear similar when used for internal mammary lymphoscintigraphy.
D000328:Adult; D000368:Aged; D000965:Antimony; D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D003102:Colloids; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D061305:Lymphoscintigraphy; D008875:Middle Aged; D011446:Prospective Studies; D013667:Technetium; D017556:Technetium Compounds; D013671:Technetium Tc 99m Sulfur Colloid
D003102:Colloids; D017556:Technetium Compounds; C019096:technetium Tc 99m antimony sulfide; D013671:Technetium Tc 99m Sulfur Colloid; D013667:Technetium; D000965:Antimony